DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer… Read More
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More
Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable… Read More
Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times… Read More
Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive… Read More
Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation… Read More
Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024… Read More
Report Finds Several Brand Name Drug Companies Waiting to Introduce New… Read More
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to… Read More
Report Finds Big Pharma Increased Spending on R&D in First Half of 2023,… Read More
Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to… Read More